Michael E. Minshall, MPH
Advertisement
Articles by Michael E. Minshall, MPH
A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.
Advertisement
Latest Updated Articles
- Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States
Published: March 1st 2008 | Updated:
- Cost-Effectiveness of Blood Glucose Monitoring Is Controversial
Published: June 7th 2008 | Updated:
- The Importance of Recognizing Patients' Time as a Cost of Self-Management
Published: June 7th 2008 | Updated:
- Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
Published: September 7th 2009 | Updated:
- A Payer's Perspective on the Cost Effectiveness of Gastric Bypass Surgery
Published: November 6th 2009 | Updated:
- Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer
Published: November 1st 1998 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
3
Jury Still Out on Testosterone Benefit to Menopause
4
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
5
